BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33396624)

  • 21. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.
    Hao Z; Zhang H; Cowell J
    Tumour Biol; 2012 Jun; 33(3):723-30. PubMed ID: 22170434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.
    Huang GZ; Chen ZQ; Wu J; Shao TR; Zou C; Ai YL; Lv XZ
    J Immunol Res; 2021; 2021():9250207. PubMed ID: 34950739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
    Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
    Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
    Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
    Tang XK; Wang KJ; Tang YK; Chen L
    Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
    Shuliang S; Lei C; Guangwu J; Changjie L
    Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma.
    Liu H; Zhu C; Xu Z; Wang J; Qian L; Zhou Q; Shen Z; Zhao W; Xiao W; Chen L; Zhou Y
    Cancer Sci; 2020 Nov; 111(11):4129-4141. PubMed ID: 32920922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions.
    Chou CP; Huang NC; Jhuang SJ; Pan HB; Peng NJ; Cheng JT; Chen CF; Chen JJ; Chang TH
    PLoS One; 2014; 9(4):e93934. PubMed ID: 24699941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of LINC00037 represses cervical cancer progression by activating mTOR signaling pathway.
    Yuan LY; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Cheng L; Xing H
    J Cell Physiol; 2019 Aug; 234(8):13353-13360. PubMed ID: 30613967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
    Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
    Song J; Xu F; An L; Yin Y; Liu J; Chai J; Yang Y; Li M; Jia Q; Wang Z
    Pathol Res Pract; 2023 Jul; 247():154577. PubMed ID: 37257243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Wang F; Tan WH; Liu W; Jin YX; Dong DD; Zhao XJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1891-1898. PubMed ID: 29687840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
    Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
    Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
    Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
    Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.
    Bose MV; Gopisetty G; Selvaluxmy G; Rajkumar T
    Int J Radiat Biol; 2012 Sep; 88(9):629-34. PubMed ID: 22694363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stathmin guides personalized therapy in oral squamous cell carcinoma.
    Ju WT; Ma HL; Zhao TC; Liang SY; Zhu DW; Wang LZ; Li J; Zhang ZY; Zhou G; Zhong LP
    Cancer Sci; 2020 Apr; 111(4):1303-1313. PubMed ID: 31994271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
    Xiong Y; Lu J; Fang Q; Lu Y; Xie C; Wu H; Yin Z
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer.
    Wang Y; Huang F; Liu M; Zhao Q
    Biochem Biophys Res Commun; 2021 Jan; 534():597-603. PubMed ID: 33223052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.